The company has created a totally new way of fighting viruses. Its nano-scale virus traps mimic human cells in order to lure viruses. The viruses are then trapped and destroyed.
The nano-scale “traps” differ from existing treatment for viral illness by targeting viruses before the viruses can affect human cells. The traps are non-toxic to the human host, avoiding the adverse side effects typical of current treatment.
Moreover, viruses cannot develop a resistance to the traps, as by doing so they would become resistance to human cells as well.
“Essentially, we are creating antibiotics for viruses,” said founder and CEO Erez Livneh, a graduate of the Weizmann Institute of Science. “The Vecoy technology will fundamentally change the treatment of viral infections.”
Company Details
- Industry
- Nanotechnology Research
- NAICS
-
Research and Development in Nanotechnology
- Keywords
- Quantum TLV.
Vecoy Questions
Vecoy's website is http://www.vecoynanomedicines.com
Vecoy's LinkedIn profile is https://www.linkedin.com/company/vecoy
Vecoy's industry is
Nanotechnology Research
Vecoy's top competitors are
Biop Medical Ltd.,
Waterwood Finance,
Khepri Animal Health,
Geyser Light Capital,
Tsd Desalination,
Israeli Digital Organization,
Cognitiv Technologies,
The Fitting Room,
Quantum Tlv,
Senex Therapeutics.
Vecoy's categories are Nanotechnology Research
